Literature DB >> 15108108

Bronchoscopic palliation of primary lung cancer: single or multimodality therapy?

R S Santos1, Y Raftopoulos, R J Keenan, A Halal, R H Maley, R J Landreneau.   

Abstract

BACKGROUND: An obstructing primary lung cancer is a challenging disease frequently requiring endobronchial interventional therapy. A variety of interventional modalities, including Nd:YAG laser, stenting, photodynamic therapy (PDT), and endoluminal brachytherapy, are utilized to relieve airway obstruction and bleeding. The aim of this study is to compare the effect on patient survival of bronchoscopic palliation for lung cancer utilizing one interventional modality compared to the use of combination of modalities to relieve the airway problem. METHODS. We reviewed our longitudinal experience with interventional bronchoscopy in 75 patients who underwent 176 procedures for the management of endobronchial lung cancer between 1994 and 2002. Indication for intervention was hemoptysis in 24 patients (32%) and airway obstruction in the remaining. Six patients died within 30 days from the first intervention and were excluded. Forty of the surviving 69 patients (58%) were treated with a single interventional modality (group A). In 29 patients (42%) a multimodality endoscopic treatment was utilized (group B). Single-modality treatment in group A included Nd-YAG laser in 60%, stent in 17%, brachytherapy in 20%, and PDT in 3%. A variety of combinations of the aforementioned modalities were used in group B to enhance airway patency. Patient data were compared with the Student's t-test and chi-square test. Survival analysis and the log rank test were used to compare difference in survival between the two groups. A p-value of 0.05 was considered significant.
RESULTS: There were 46 males and 23 females, with a mean age of 67 years. The tumor was located in the trachea 9%, in the carina in 7%, and primary bronchial in 84%. Two patients had complications due to stent malposition. There was no significant difference between the two groups in relation to age, gender, tumor location, histology, and type of previous cancer therapy. There was a significant improvement in survival for the multimodality group (p = 0.04). The 1- and 3-year cumulative survival rate for groups A and B was 51.3% versus 50% and 2.3% versus 22%, respectively.
CONCLUSIONS: Improvement in survival can be seen with diligent airway surveillance after interventional bronchoscopy and liberal use of a variety of endobronchial treatment modalities for airway obstruction or bleeding. Physicians involved in the management of this difficult problem should be versed in the use of all available treatment modalities to enhance therapeutic outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15108108     DOI: 10.1007/s00464-003-9202-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

1.  Complications associated with brachytherapy alone or with laser in lung cancer.

Authors:  B Khanavkar; P Stern; W Alberti; J A Nakhosteen
Journal:  Chest       Date:  1991-05       Impact factor: 9.410

Review 2.  Therapeutic bronchoscopy in lung cancer. Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy.

Authors:  Pyng Lee; Elif Kupeli; Atul C Mehta
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

3.  An international comparison of tobacco smoking, beliefs and risk awareness in university students from 23 countries.

Authors:  Andrew Steptoe; Jane Wardle; Weiwei Cui; Adriana Baban; Kelli Glass; Akira Tsuda; Jan Vinck
Journal:  Addiction       Date:  2002-12       Impact factor: 6.526

4.  Nd-YAG laser vs bronchoscopic electrocautery for palliation of symptomatic airway obstruction: a cost-effectiveness study.

Authors:  T v Boxem; M Muller; B Venmans; P Postmus; T Sutedja
Journal:  Chest       Date:  1999-10       Impact factor: 9.410

5.  Nasotracheal jet ventilation for rigid endoscopy.

Authors:  M J Magee; M Klain; P F Ferson; R J Keenan; R J Landreneau
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

6.  Endoscopic relief of malignant airway obstruction.

Authors:  D J Mathisen; H C Grillo
Journal:  Ann Thorac Surg       Date:  1989-10       Impact factor: 4.330

Review 7.  Airway stenting.

Authors:  D E Wood
Journal:  Chest Surg Clin N Am       Date:  2001-11

Review 8.  Endobronchial brachytherapy.

Authors:  A G Villanueva; T C Lo; J F Beamis
Journal:  Clin Chest Med       Date:  1995-09       Impact factor: 2.878

9.  Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma.

Authors:  D A Cortese; J H Kinsey
Journal:  Chest       Date:  1984-07       Impact factor: 9.410

10.  Endobronchial management of benign, malignant, and lung transplantation airway stenoses.

Authors:  J R Sonett; R J Keenan; P F Ferson; B P Griffith; R J Landreneau
Journal:  Ann Thorac Surg       Date:  1995-06       Impact factor: 4.330

View more
  12 in total

1.  The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer.

Authors:  Kinya Furukawa; Junzo Ishida; Gaku Yamaguchi; Jitsuo Usuda; Hidemitsu Tsutsui; Makoto Saito; Chimori Konaka; Harubumi Kato
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

Review 2.  [Endoscopic interventions in pulmonology].

Authors:  D Gompelmann; F J F Herth
Journal:  Internist (Berl)       Date:  2016-08       Impact factor: 0.743

3.  Photodynamic therapy for the treatment of non-small cell lung cancer.

Authors:  Charles B Simone; Joseph S Friedberg; Eli Glatstein; James P Stevenson; Daniel H Sterman; Stephen M Hahn; Keith A Cengel
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

4.  Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin.

Authors:  Hiren J Mehta; Abbie Begnaud; Andrea M Penley; John Wynne; Paras Malhotra; Sebastian Fernandez-Bussy; Jessica Cope; Jonathan J Shuster; Michael A Jantz
Journal:  Ann Am Thorac Soc       Date:  2015-09

Review 5.  From electrocautery, balloon dilatation, neodymium-doped:yttrium-aluminum-garnet (Nd:YAG) laser to argon plasma coagulation and cryotherapy.

Authors:  Ashutosh Sachdeva; Edward M Pickering; Hans J Lee
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Outcomes of patients with advanced non-small cell lung cancer and airway obstruction treated with photodynamic therapy and non-photodynamic therapy ablation modalities.

Authors:  Ravishankar Jayadevappa; Sumedha Chhatre; Harmik J Soukiasian; Septimiu Murgu
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

7.  Survival and Quality of Life Benefit after Endoscopic Management of Malignant Central Airway Obstruction.

Authors:  Grigoris Stratakos; Vasiliki Gerovasili; Charalampos Dimitropoulos; Ioannis Giozos; Filippos T Filippidis; Sofia Gennimata; Paul Zarogoulidis; Athanasios Zissimopoulos; Athanasia Pataka; Nikos Koufos; Spyros Zakynthinos; Konstantinos Syrigos; Nikos Koulouris
Journal:  J Cancer       Date:  2016-04-25       Impact factor: 4.207

8.  Prognostic factors for survival after bronchoscopic intervention in patients with airway obstruction due to primary pulmonary malignancy.

Authors:  Bo-Guen Kim; Beomsu Shin; Boksoon Chang; Hojoong Kim; Byeong-Ho Jeong
Journal:  BMC Pulm Med       Date:  2020-02-27       Impact factor: 3.317

9.  Patient-related independent clinical risk factors for early complications following Nd: YAG laser resection of lung cancer.

Authors:  Branislav Perin; Bojan Zaric; Svetlana Jovanovic; Jovan Matijasevic; Jelena Stanic; Ivan Kopitovic; Biljana Zvezdin; Milan Antonic
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

Review 10.  Photodynamic Therapy in Non-Gastrointestinal Thoracic Malignancies.

Authors:  Biniam Kidane; Dhruvin Hirpara; Kazuhiro Yasufuku
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.